Evidence map›Paper›PMID 34471023›Full record

ArticleInternal medicine (Tokyo, Japan)2022

CD56-positive Angioimmunoblastic T-cell Lymphoma Complicated by Chylothorax.

Hiroki Hori, Yasuhiro Tanaka, Ryuko Nakayama, Masaharu Nohgawa

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. CD56 on immune and tumor cells: what is known and beyond?Clinical and experimental immunology · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hiroki HoriDepartment of Hematology, Japanese Red Cross Wakayama Medical Center, Japan.
Yasuhiro TanakaDepartment of Hematology, Japanese Red Cross Wakayama Medical Center, Japan.
Ryuko NakayamaDepartment of Diagnostic Pathology, Japanese Red Cross Wakayama Medical Center, Japan.
Masaharu NohgawaDepartment of Hematology, Japanese Red Cross Wakayama Medical Center, Japan.
Japanese Red Cross Society Wakayama Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 77-year-old woman presented with systemic lymphadenopathy and bilateral pleural effusion. Angioimmunoblastic T-cell lymphoma (AITL) was diagnosed based on the results of a lymph node biopsy. AITL cells expressed the aberrant antigen of CD56. The bilateral pleural effusion was attributed to chylothorax, not the infiltration of lymphoma cells into the pleura, as determined by the pleural fluid analysis. We therefore diagnosed her with CD56-positive AITL complicated by chylothorax. She achieved complete remission by multidrug chemotherapy. AITL is commonly complicated by pleural effusion, but rarely by chylothorax. This is the first case of CD56-positive AITL complicated by chylothorax.

Indexed as

ChylothoraxImmunoblastic LymphadenopathyLymphoma, T-CellPleural EffusionAgedFemaleHumansPleuraangioimmunoblastic T-cell lymphomaCD56 positivitychylothoraxpleural effusion

Identifiers

PMID34471023
PMCPMC8943380
OpenAlexW3198346071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.